Search | Page 7 | Aplastic Anemia and MDS International Foundation


Search results

  1. Eltrombopag: Recent Discoveries on Potential New Applications for Aplastic Anemia

    ... it work when applied to aplastic anemia ? This is a drug that is already FDA-approved to treat another blood disorder called ... other treatments, which were most often multiple rounds of immunosuppressive therapy. This is known as refractory SAA. When tested ...

    Interview last updated 02/14/2014 - 2:01pm.

  2. Supportive Care

    ... to remove the extra iron out of your body. The U.S. Food and Drug Administration (FDA) has approved two iron chelators to treat iron ... may be helpful for some patients, but they do not replace immunosuppressive therapy. Red cell growth factor is called ...

    Page last updated 08/29/2013 - 4:20pm.

  3. 2014 Scholarships Awarded to Special Group of Young People

    ... Institutes of Health (NIH) where she received successful immunosuppressive treatment while enrolled in a clinical trial and ... to be a part of that” contributing to medical research and drug development. Because of his post-transplant issues, the 17-year-old is ...

    Page last updated 10/22/2015 - 8:28am.

  4. Transplantation Update

    ... transplants from unrelated donors after having failed immunosuppressive therapy, this study was to answer the question is it possible ... because there was failure of engraftment when this drug was not used.  However, smaller doses (50 or 100 mg per kg) of ...

    Interview last updated 05/14/2015 - 2:42pm.

  5. 2013 Scholarships Awarded to Special Group of Young People

    ... blood and platelet transfusions and being treated with immunosuppressive medications. To show his determination to keep pace, while he ... were caused mostly from being sedentary for too long and the drug treatments. Both of these things are temporary side effects, and will pass ...

    Page last updated 06/24/2015 - 10:22am.

  6. Clinical Trials Report for February 2015

    ... severe aplastic anemia (SAA) who have failed to respond to immunosuppressive therapy and lack an HLA identical family member, our ... to control MM and/or low-int-1 risk MDS. The safety of this drug combination will also be studied. hATG is made from horse blood and ...

    Page last updated 01/29/2015 - 10:10am.

  7. Lower-Risk MDS: Diagnosis and Treatment Options

    ... patients have a very good chance of responding to a drug called lenalidomide (Revlimid®), with about a 75% chance ... There is also a small group of patients who respond to immunosuppressive treatments. In aplastic anemia , there is a high ...

    Interview last updated 05/18/2012 - 1:28pm.